ZIDOVUDINE Drug Patent Profile
✉ Email this page to a colleague
When do Zidovudine patents expire, and when can generic versions of Zidovudine launch?
Zidovudine is a drug marketed by Aurobindo Pharma Ltd, Cipla Ltd, Am Regent, Liaoning Chengda, Aurobindo, Aurobindo Pharma, Cipla, Hec Pharm, Hetero Labs Ltd Iii, Hikma, Norvium Bioscience, and Ranbaxy Labs Ltd. and is included in fifteen NDAs.
The generic ingredient in ZIDOVUDINE is zidovudine. There are twenty-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the zidovudine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zidovudine
A generic version of ZIDOVUDINE was approved as zidovudine by AUROBINDO on September 19th, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ZIDOVUDINE?
- What are the global sales for ZIDOVUDINE?
- What is Average Wholesale Price for ZIDOVUDINE?
Summary for ZIDOVUDINE
| US Patents: | 0 |
| Applicants: | 12 |
| NDAs: | 15 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 102 |
| Clinical Trials: | 524 |
| Drug Prices: | Drug price information for ZIDOVUDINE |
| DailyMed Link: | ZIDOVUDINE at DailyMed |
Recent Clinical Trials for ZIDOVUDINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Inflammasome Therapeutics | Phase 1 |
| Michelle Abou-Jaoude | Phase 1 |
| The Aurum Institute NPC | Phase 1/Phase 2 |
Pharmacology for ZIDOVUDINE
Medical Subject Heading (MeSH) Categories for ZIDOVUDINE
Anatomical Therapeutic Chemical (ATC) Classes for ZIDOVUDINE
US Patents and Regulatory Information for ZIDOVUDINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Ltd | ZIDOVUDINE | zidovudine | CAPSULE;ORAL | 078128-001 | Mar 27, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Aurobindo | ZIDOVUDINE | zidovudine | TABLET;ORAL | 077267-001 | Sep 19, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Liaoning Chengda | ZIDOVUDINE | zidovudine | INJECTABLE;INJECTION | 204538-001 | Nov 26, 2013 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hikma | ZIDOVUDINE | zidovudine | TABLET;ORAL | 076844-001 | Sep 19, 2005 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Aurobindo Pharma | ZIDOVUDINE | zidovudine | TABLET;ORAL | 022294-001 | Jul 23, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Norvium Bioscience | ZIDOVUDINE | zidovudine | TABLET;ORAL | 078922-001 | Feb 14, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
